Endoscopic retrograde cholangiopancreatography-induced and non-endoscopic retrograde cholangiopancreatography-induced acute pancreatitis: Two distinct clinical and immunological entities?

Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Endoscopic retrograde cholangiopancreatography (ERCP) is an essential modality for the diagnosis and therapy of pancreatobiliary disease. However, complications of ERCP-related procedures are also common. Post-ERCP pancreatitis (PEP), the most common and potentially serious complication of ERCP-related procedures, occurs in 1 9% of all procedures (1-16). Moreover, the PEP rate increases to 10 4...

Endoscopic retrograde cholangiopancreatography after acute pancreatitis.

To assess the usefulness of endoscopic retrograde cholangiography (ERCP) in the study of acute pancreatitis, 101 of a possible 114 patients (89 per cent) with acute pancreatitis underwent ERCP after recovery from acute illness. In 81 per cent, ERCP was performed within two weeks of recovery. The biliary tract was successfully demonstrated in 87 per cent of the patients and the pancreatic duct i...

Endoscopic Retrograde Cholangiopancreatography (ERCP) Related Acute Pancreatitis

Post-endoscopic retrograde cholangiopancreatography pancreatitis

Acute pancreatitis remains the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). It is reported to occur in 2-10% of unselected patient samples and up to 40% of high-risk patients. The purpose of this article is to review the evidence behind the known risk factors for post-ERCP pancreatitis, as well as the technical and medical approaches developed to prevent it...

Endoscopic retrograde cholangiopancreatography (E.R.C.P.).